CardioScan® identifies individuals with elevated risk for CVD.
🫀 CardioScan® Cardiovascular Disease Risk Test
The CardioScan® Cardiovascular Disease Risk Test is a sophisticated, non-invasive molecular diagnostic test designed to provide a detailed assessment of an individual's genetic and biochemical risk factors for developing Cardiovascular Disease (CVD), including coronary artery disease, stroke, and heart attack.
🔬 What the Test Measures
The CardioScan® test goes beyond standard cholesterol panels by analyzing key biological markers that contribute to the chronic inflammatory and atherogenic processes underlying CVD. It typically focuses on:
Genetic Markers (SNPs): Analysis of specific Single Nucleotide Polymorphisms (SNPs) in genes related to:
Lipid Metabolism: APOE Gene that affect how the body processes cholesterol and triglycerides.
🎯 Purpose and Clinical Utility
The primary purpose of the CardioScan® test is to proactively identify individuals who may be at elevated risk for CVD before symptoms manifest or traditional risk factors become severe.
Personalized Risk Stratification: It provides a comprehensive, individualized risk score that can help clinicians better manage patients who have intermediate or borderline risk based on conventional factors.
Targeted Interventions: The specific data on genetic and inflammatory pathways allows for the development of highly personalized prevention and treatment strategies, including targeted nutritional changes, lifestyle modifications, or pharmacologic therapy.
Motivation for Lifestyle Change: Understanding one's genetic predisposition can be a powerful motivator for patients to adhere to crucial preventative health behaviors.
